TheraKine Receives Patent for Formulation Method That Enables Sustained Release of Injectable Drug
TheraKine Ltd. today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 86310619, a key patent for its innovative sustained-release formulation of injectable drugs.
View full press release